Myomo, Inc.

MYO NYSE SEC CIK 1369290
Follow Myomo Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $12.3M +22.2% vs same quarter last year
Net income −$4.2M −15.6% vs same quarter last year
EPS, diluted −$0.10 −11.1% vs same quarter last year
Operating cash flow −$1.3M +28.6% vs same quarter last year
Revenue by quarter
$12.1M
$9.8M
$9.7M
$10.1M
$11.4M
$10.1M
$11.7M
$12.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income11 fiscal years
  • Revenue
  • Net income
−$20M$0$20M$40M$60MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$40.9M−$15.6M
FY24$32.6M−$6.2M
FY23$19.2M−$8.1M
FY22$15.6M−$10.7M
FY21$13.9M−$10.4M
FY20$7.6M−$11.6M
FY19$3.8M−$10.7M
FY18$2.4M−$10.3M
FY17$1.6M−$12.1M
FY16$1.1M−$3.6M
FY15--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000%−750%−500%−250%0%250%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2565.7%−35.2%−38.1%
FY2471.2%−19.1%−19%
FY2368.5%−42.8%−42.1%
FY2265.9%−68.6%−68.9%
FY2174.4%−74.1%−74.9%
FY2065.7%−138.5%−152.5%
FY1963%−281.3%−279.1%
FY1870.2%−430.8%−422.1%
FY1767.6%−420.1%−776%
FY1674.4%−296.8%−327.8%
FY15---
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$16.3M
FY24−$4.7M
FY23−$6.3M
FY22−$10.3M
FY21−$9.9M
FY20−$9.1M
FY19−$10.4M
FY18−$9.7M
FY17−$6.2M
FY16−$3.2M
FY15-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Myomo
  • Healthcare median
−800%−600%−400%−200%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearMyomoHealthcare median
FY25−38.1%−30.6%
FY24−19%−47%
FY23−42.1%−58%
FY22−68.9%−80.4%
FY21−74.9%−71.9%
FY20−152.5%−62.2%
FY19−279.1%−46.3%
FY18−422.1%−49.6%
FY17−776%−45.9%
FY16−327.8%−36%
FY15-−38.4%